FDA approves Olumiant as first systemic therapy for treatment of alopecia areata Dr. Kamal Kant Kohli15 Jun 2022 3:30 AM GMTThe U.S. Food and Drug Administration has approved Olumiant as first systemic therapy for the treatment of alopecia areata.Olumiant...
Roflumilast foam useful in patients with moderate to severe seborrheic dermatitis, reveals phase 3 trial Dr. Kamal Kant Kohli12 Jun 2022 2:00 PM GMTWESTLAKE VILLAGE, Calif: Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing meaningful...
FDA approves dupilumab for treatment of atopic dermatitis in pediatric patients Dr. Kamal Kant Kohli10 Jun 2022 3:30 AM GMTTARRYTOWN, N.Y. and PARIS: The U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for children aged 6 months to 5 years with...
Menthol cigarettes increase youth smoking, nicotine addiction Dr. Nandita Mohan8 Jun 2022 4:45 AM GMTResearchers have noted that the proportion of 12- to 17-year-old cigarette smokers who smoke menthol has risen to 56% and these menthol cigarettes...
Intake of 5-ARIs for BPH not associated with increased mortality in prostate cancer Dr. Kamal Kant Kohli7 Jun 2022 2:00 PM GMTResearchers have found in a new study that Intake of 5-ARIs for BPH is not associated with increased mortality in prostate cancer. The study has been...
FDA approves treprostinil dry powder inhaler for treatment of PAH Dr. Kamal Kant Kohli27 May 2022 4:45 AM GMTThe Food and Drug Administration (FDA) has granted approval to Tyvaso DPI (treprostinil) inhalation powder for treating pulmonary arterial...
Paclitaxel devices show no increased mortality compared to non-drug coated devices: SAFE-PAD study Dr. Kamal Kant Kohli23 May 2022 2:00 PM GMTOngoing long-term follow-up of Medicare patients who received paclitaxel-coated devices for the treatment of PAD continues to show no evidence of an...
FDA approves dupilumab as first Treatment for Eosinophilic Esophagitis Dr. Kamal Kant Kohli23 May 2022 3:45 AM GMTDupilumab (Dupixent, Regeneron Pharmaceuticals, Inc.) is first drug in the U.S. specifically indicated for the treatment of eosinophilic...
Changed policy for use of erythropoietin stimulating agents has lowered MACE in kidney failure patients Dr. Kamal Kant Kohli22 May 2022 2:00 PM GMTWashington, DC: A recent study published in CJASN has investigated how 2011 changes to anemia care have impacted clinical outcomes among patients with...
FDA authorizes wearable neuromodulation device for fibromyalgia Dr. Kamal Kant Kohli22 May 2022 2:00 PM GMTFood and Drug administration has authorized use of Quell® neuromodulation device as an aid in reducing the symptoms of fibromyalgia in adults with...
Abaloparatide Effective In Ignored Population: Men With Osteoporosis Dr. Nandita Mohan21 May 2022 4:00 AM GMTOsteoporosis is commonly known as a "silent disease" because it progresses without symptoms until afracture occurs. It develops less often in men than...
FDA approves third dose of Pfizer COVID-19 vaccine for kids between 5 to 11 years Dr. Kamal Kant Kohli18 May 2022 3:51 AM GMTThe U.S. Food and Drug Administration has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to include the use...
